Brighthouse Financial . Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Brighthouse Financial . Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|---|---|
| net cash from operating activities | -1,000,000 | 146,000,000 | -118,000,000 | 24,000,000 | 334,000,000 | -530,000,000 | 152,000,000 | -500,000,000 |
| cash flows from investing activities | ||||||||
| sales, maturities and repayments of: | ||||||||
| fixed maturity securities | 3,062,000,000 | 3,140,000,000 | 3,753,000,000 | 2,418,000,000 | 3,273,000,000 | 2,277,000,000 | 1,440,000,000 | 1,474,000,000 |
| trading securities | 0 | 6,000,000 | ||||||
| equity securities | 18,000,000 | 12,000,000 | 12,000,000 | 2,000,000 | 8,000,000 | 24,000,000 | 17,000,000 | 2,000,000 |
| mortgage loans | 681,000,000 | 448,000,000 | 490,000,000 | 348,000,000 | 404,000,000 | 281,000,000 | 328,000,000 | 262,000,000 |
| limited partnerships and limited liability companies | 109,000,000 | 87,000,000 | 110,000,000 | 72,000,000 | 77,000,000 | 78,000,000 | 69,000,000 | 37,000,000 |
| purchases of: | ||||||||
| cash received in connection with freestanding derivatives | 1,984,000,000 | 3,348,000,000 | 3,815,000,000 | 3,026,000,000 | 2,063,000,000 | 3,564,000,000 | 1,066,000,000 | 1,106,000,000 |
| cash paid in connection with freestanding derivatives | -2,856,000,000 | -4,110,000,000 | -3,217,000,000 | -2,905,000,000 | -2,569,000,000 | -3,174,000,000 | -788,000,000 | -1,758,000,000 |
| net change in policy loans | 11,000,000 | 588,000,000 | -636,000,000 | 82,000,000 | 182,000,000 | -320,000,000 | -20,000,000 | 9,000,000 |
| net change in short-term investments | 412,000,000 | 318,000,000 | -47,000,000 | -408,000,000 | -33,000,000 | -187,000,000 | -150,000,000 | -299,000,000 |
| net change in other invested assets | -77,000,000 | -104,000,000 | 11,000,000 | -202,000,000 | 5,000,000 | -19,000,000 | ||
| net cash from investing activities | 112,000,000 | 563,000,000 | -357,000,000 | -130,000,000 | -1,082,000,000 | -625,000,000 | -552,000,000 | -1,325,000,000 |
| cash flows from financing activities | ||||||||
| policyholder account balances: | ||||||||
| deposits | 4,699,000,000 | 5,135,000,000 | -8,731,000,000 | 18,509,000,000 | 12,818,000,000 | 7,814,000,000 | 5,697,000,000 | 6,864,000,000 |
| withdrawals | -4,012,000,000 | -5,968,000,000 | 9,091,000,000 | -17,460,000,000 | -11,562,000,000 | -6,447,000,000 | -4,974,000,000 | -5,298,000,000 |
| net change in payables for collateral under securities loaned and other transactions | 90,000,000 | 13,000,000 | 127,000,000 | -142,000,000 | 253,000,000 | -17,000,000 | -271,000,000 | -159,000,000 |
| long-term debt repaid | -1,000,000 | 0 | -1,000,000 | |||||
| dividends on preferred stock | -25,000,000 | -26,000,000 | -25,000,000 | -26,000,000 | -25,000,000 | -26,000,000 | -25,000,000 | -26,000,000 |
| treasury stock acquired in connection with share repurchases | -43,000,000 | -59,000,000 | -60,000,000 | -64,000,000 | -64,000,000 | -62,000,000 | -60,000,000 | -62,000,000 |
| financing element on certain derivative instruments and other derivative related transactions | 53,000,000 | -167,000,000 | -509,000,000 | 480,000,000 | -53,000,000 | -122,000,000 | 47,000,000 | 91,000,000 |
| other | 1,000,000 | -15,000,000 | 34,000,000 | 9,000,000 | 0 | -13,000,000 | 57,000,000 | -15,000,000 |
| net cash from financing activities | 762,000,000 | -1,087,000,000 | -110,000,000 | 1,295,000,000 | 1,366,000,000 | 1,127,000,000 | 412,000,000 | 1,395,000,000 |
| change in cash, cash equivalents and restricted cash | 873,000,000 | -378,000,000 | -585,000,000 | 1,189,000,000 | 618,000,000 | -28,000,000 | 12,000,000 | -430,000,000 |
| cash, cash equivalents and restricted cash, beginning of period | 0 | 5,045,000,000 | 0 | 0 | 3,851,000,000 | 4,115,000,000 | ||
| cash, cash equivalents and restricted cash, end of period | 873,000,000 | 4,667,000,000 | 1,189,000,000 | 618,000,000 | 3,823,000,000 | 3,685,000,000 | ||
| supplemental disclosures of cash flow information | ||||||||
| net cash paid (received) for: | ||||||||
| interest | 69,000,000 | 6,000,000 | 69,000,000 | 7,000,000 | 69,000,000 | 6,000,000 | 69,000,000 | 6,000,000 |
| income tax | 3,000,000 | 7,000,000 | 3,000,000 | 4,000,000 | 2,000,000 | 4,000,000 | 6,000,000 | -9,000,000 |
| cash flows from operating activities | ||||||||
| net income | ||||||||
| adjustments to reconcile net income to net cash from operating activities: | ||||||||
| amortization of premiums and accretion of discounts associated with investments | ||||||||
| (gains) losses on investments | ||||||||
| (gains) losses on derivatives | ||||||||
| (income) income from equity method investments, net of dividends and distributions | ||||||||
| interest credited to policyholder account balances | ||||||||
| universal life and investment-type product policy fees | ||||||||
| change in market risk benefits | ||||||||
| change in accrued investment income | ||||||||
| change in premiums, reinsurance and other receivables | ||||||||
| change in deferred policy acquisition costs and value of business acquired | ||||||||
| change in income tax | ||||||||
| change in other assets | ||||||||
| change in future policy benefits and other policy-related balances | ||||||||
| change in other liabilities | ||||||||
| cash, cash equivalents and restricted cash, beginning of year | ||||||||
| cash, cash equivalents and restricted cash, end of year | ||||||||
| non-cash transactions: | ||||||||
| transfer of mortgage loans to affiliates | ||||||||
| transfer of limited partnerships and limited liability companies from affiliates | ||||||||
| long-term debt issued | ||||||||
| preferred stock issued, net of issuance costs |
We provide you with 20 years of cash flow statements for Brighthouse Financial . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Brighthouse Financial . stock. Explore the full financial landscape of Brighthouse Financial . stock with our expertly curated income statements.
The information provided in this report about Brighthouse Financial . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.